These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study. Rengan R; Mitra N; Liao K; Armstrong K; Vachani A Lancet Oncol; 2012 Dec; 13(12):1203-9. PubMed ID: 23164952 [TBL] [Abstract][Full Text] [Related]
4. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. Lavolé A; Chouaïd C; Baudrin L; Wislez M; Raguin G; Pialoux G; Girard PM; Milleron B; Cadranel J Lung Cancer; 2009 Sep; 65(3):345-50. PubMed ID: 19135758 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer. Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649 [TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study. Makinson A; Tenon JC; Eymard-Duvernay S; Pujol JL; Allavena C; Cuzin L; Poizot-Martin I; de la Tribonnière X; Cabié A; Pugliese P; Reynes J; Le Moing V J Thorac Oncol; 2011 Jun; 6(6):1022-9. PubMed ID: 21512403 [TBL] [Abstract][Full Text] [Related]
7. Marital status independently predicts non-small cell lung cancer survival: a propensity-adjusted SEER database analysis. Chen Z; Yin K; Zheng D; Gu J; Luo J; Wang S; Chen H J Cancer Res Clin Oncol; 2020 Jan; 146(1):67-74. PubMed ID: 31786738 [TBL] [Abstract][Full Text] [Related]
8. Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals. Suneja G; Shiels MS; Melville SK; Williams MA; Rengan R; Engels EA AIDS; 2013 Jan; 27(3):459-68. PubMed ID: 23079809 [TBL] [Abstract][Full Text] [Related]
9. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients. Budnik J; DeNunzio NJ; Singh DP; Milano MT Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310 [TBL] [Abstract][Full Text] [Related]
10. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database. Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464 [TBL] [Abstract][Full Text] [Related]
11. Mortality among people living with HIV/AIDS with non-small-cell lung cancer in the modern HAART Era. Smith DM; Salters KA; Eyawo O; Franco-Villalobos C; Jabbari S; Wiseman SM; Press N; Montaner JSG; Man SFP; Hull M; Hogg RS AIDS Care; 2018 Jul; 30(7):936-942. PubMed ID: 29411625 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis. Malhotra J; Mhango G; Gomez JE; Smith C; Galsky MD; Strauss GM; Wisnivesky JP Ann Oncol; 2015 Apr; 26(4):768-773. PubMed ID: 25600562 [TBL] [Abstract][Full Text] [Related]
13. Survival of patients with stage IV lung cancer with diabetes treated with metformin. Lin JJ; Gallagher EJ; Sigel K; Mhango G; Galsky MD; Smith CB; LeRoith D; Wisnivesky JP Am J Respir Crit Care Med; 2015 Feb; 191(4):448-54. PubMed ID: 25522257 [TBL] [Abstract][Full Text] [Related]
14. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis. Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199 [TBL] [Abstract][Full Text] [Related]
15. Decreased Overall Survival in HIV-associated Non-small-cell Lung Cancer. Hysell K; Yusuf R; Barakat L; Virata M; Gan G; Deng Y; Perez-Irizarry J; Vega T; Goldberg SB; Emu B Clin Lung Cancer; 2021 Jul; 22(4):e498-e505. PubMed ID: 33468393 [TBL] [Abstract][Full Text] [Related]
16. Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest. Zeliadt SB; Sekaran NK; Hu EY; Slatore CC; Au DH; Backhus L; Wu DY; Crawford J; Lyman GH; Dale DC J Thorac Oncol; 2011 Oct; 6(10):1726-32. PubMed ID: 21857253 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion. Hu ZG; Hu K; Li WX; Zeng FJ PLoS One; 2019; 14(5):e0217007. PubMed ID: 31095610 [TBL] [Abstract][Full Text] [Related]
18. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data. Kates M; Swanson S; Wisnivesky JP Chest; 2011 Mar; 139(3):491-496. PubMed ID: 20576736 [TBL] [Abstract][Full Text] [Related]
19. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients. Milano MT; Li H; Constine LS; Travis LB Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074 [TBL] [Abstract][Full Text] [Related]
20. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database. Osarogiagbon RU; Yu X J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]